Graft-versus-Host Disease-Free Relapse-Free Survival Definition for Patients with Nonmalignant Hematologic Disorders

Maria Queralt Salas1, Rajat Kumar1

  • 1Department of Internal Medicine, Section of Medical Oncology and Hematology, University of Toronto, Toronto, Ontario, Canada; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

Abstract

No abstract available in PubMed .